Encompass Health (EHC) director receives 1,634-share restricted stock grant

Rhea-AI Filing Summary

Reidy Christopher R reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Christopher R. Reidy received an equity grant of 1,634 shares of Encompass Health Common Stock. The shares were awarded at a price of $0.00 per share as part of his annual grant of restricted stock units under the corporation's 2025 Omnibus Performance Incentive Plan.

Following this grant, Reidy directly holds 17,437 shares of Encompass Health Common Stock. This transaction reflects a compensation-related award rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Reidy Christopher R

Role null

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	1,634	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 17,437 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 1,634 shares Grant price per share: $0.00 per share Shares held after transaction: 17,437 shares +1 more

4 metrics

Shares granted 1,634 shares Annual restricted stock unit grant on May 7, 2026

Grant price per share $0.00 per share Equity award compensation, not an open-market purchase

Shares held after transaction 17,437 shares Christopher R. Reidy direct ownership following grant

Transaction direction Acquisition via grant/award Form 4 code A, grant or award acquisition

Key Terms

restricted stock units, 2025 Omnibus Performance Incentive Plan, grant, award, or other acquisition

3 terms

restricted stock units financial

"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Performance Incentive Plan financial

"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reidy Christopher R

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	05/07/2026		A		1,634(1)	A	$0	17,437	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

	/s/ Patrick Darby, attorney-in-fact for Christopher R. Reidy	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Encompass Health (EHC) report for Christopher R. Reidy?

Encompass Health reported that director Christopher R. Reidy received a grant of 1,634 shares of Encompass Health Common Stock. The award was part of his annual restricted stock unit grant under the company’s 2025 Omnibus Performance Incentive Plan, recorded on a Form 4 filing.

How many Encompass Health (EHC) shares does Christopher R. Reidy hold after this Form 4 transaction?

After the grant, Christopher R. Reidy directly holds 17,437 shares of Encompass Health Common Stock. This total reflects his position following the award of 1,634 restricted stock units granted under the company’s 2025 Omnibus Performance Incentive Plan as disclosed in the Form 4.

Was cash paid for Christopher R. Reidy’s Encompass Health (EHC) share grant?

No cash was paid for this grant; the reported transaction price per share was $0.00. The 1,634 shares were issued as an equity-based compensation award of restricted stock units under Encompass Health’s 2025 Omnibus Performance Incentive Plan.

What is the nature of the equity award reported for Encompass Health (EHC) director Christopher R. Reidy?

The award is an annual grant of restricted stock units under Encompass Health’s 2025 Omnibus Performance Incentive Plan. It represents a compensation-related acquisition of 1,634 shares, rather than an open-market purchase or sale, and is categorized as a grant or award acquisition.

Does the Encompass Health (EHC) Form 4 show a buy or sell by Christopher R. Reidy?

The Form 4 does not show a buy or sell transaction; it records an acquisition through a grant or award. Christopher R. Reidy received 1,634 shares as restricted stock units, increasing his direct holdings to 17,437 Encompass Health Common Stock shares.